Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...

Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd. New York, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Revium Recovery, Inc. (OTC Pink: RVRC) or ("RVRC) has entered into a non-binding letter of intent to acquire LipoVac, Ltd. ("LipoVac"), a privately...

Hebrew University to Collaborate with Cytovia Therapeutics NEW YORK and JERUSALEM, March 18, 2020 (GLOBE NEWSWIRE) -- Yissum, the technology transfer company of The Hebrew University of Jerusalem and Cytovia Therapeutics, Inc, a biopharmaceutical company...

NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic BOCA RATON, Fla. and JERUSALEM, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on stem-cell-based diagnostic technology to...

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.Appoints New Board of Directors Led by Jan Loeb as ChairmanForms New Leadership Team with Deep Healthcare ExpertisePlans...